Shares of Aurobindo Pharma surged 8 per cent on the BSE on Monday to ₹998 on incentive booster. The company’s project for production of penicillin G has been approved by the Centre under the Production Linked Incentive scheme for promoting domestic manufacture of bulk drugs and active pharmaceutical ingredients.
The project has a committed production capacity of 15,000 tonnes of penicillin G with an investment of ₹1,392 crore.
The commercial production is projected to commence from 2023-24. The project will also enhance the company's backward integration in antibiotics and open-up new revenue streams to support its growth prospects, said analysts.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.